Drug-coated balloon in peripheral artery disease

Madhan Shanmugasundaram, Sangeetha Murugapandian, Huu Tam Truong, Kapildeo Lotun, Subhash Banerjee

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Peripheral artery disease (PAD) is highly prevalent but is often underdiagnosed and undertreated. Lower extremity PAD can often be life style limiting. Revascularization in carefully selected lower extremity PAD patients improves symptoms and functional status. Surgical revascularization used to be the only available strategy, but in the recent years, endovascular strategies have gained popularity due to faster recovery times with low morbidity and mortality rates. Endovascular procedures have increased significantly in the United States in the past few years. That being said, higher restenosis rates and low long-term patency rates have been the limiting factors for this strategy. Drug eluting stents have been introduced to help with lowering restenosis, however lower extremity PAD involves long segment where the outcomes of stents are suboptimal. Also, the disease often crosses joint line that makes it less ideal for the stents. Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”. This is a review of scientific evidence supporting DCB use in PAD.

Original languageEnglish (US)
Pages (from-to)338-343
Number of pages6
JournalCardiovascular Revascularization Medicine
Issue number4
StatePublished - Apr 2019


  • Drug-coated balloon
  • Endovascular interventions
  • Peripheral artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Drug-coated balloon in peripheral artery disease'. Together they form a unique fingerprint.

Cite this